Briefs: Torrent Pharmaceuticals and Laurus Synthesis
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Leading USA based genetic testing brand officially enters the Indian market
Express Scripts to add Zepbound to National Preferred Formulary
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
The product will be manufactured at Lupin’s Nagpur facility in India
Subscribe To Our Newsletter & Stay Updated